Journal of Intensive Medicine

Journal of Intensive Medicine is an open access journal owned by the Chinese Medical Association and published by Elsevier since 2021, covering all aspects of intensive care medicine, with a 2025 Journal Impact Factor of 5.6.《重症医学杂志》由（Chinese Medical Association）拥有、由（Elsevier）自 2021 年起出版，为开放获取期刊，覆盖重症医学的各个方面，2025 年期刊影响因子为 5.6。

Scope

• The journal publishes review papers and original research on trends and advances across intensive care medicine.刊物发表综述与原创研究，追踪重症医学各方向的趋势与进展。
• Clinical subject matter includes septic shock, acute respiratory distress syndrome and other forms of organ failure.临床主题包括感染性休克、急性呼吸窘迫综合征及其他类型的器官功能衰竭。
• Haemodynamics, fluid resuscitation and cardiopulmonary interaction form a distinct clinical strand.血流动力学、液体复苏与心肺交互作用构成独立的临床主线。
• Mechanical ventilation, extracorporeal support and other organ support techniques are within the remit.机械通气、体外支持及其他器官支持技术均在收录范围之内。
• Infection, antimicrobial use and the role of the microbiome in critical illness are covered.感染、抗菌药物使用，以及微生物组在危重症中的作用，同样被覆盖。
• Nutrition, sedation, neurointensive care and end-of-life care in the ICU are treated as core subjects rather than adjuncts.营养、镇静、神经重症与重症监护终末期照护，被视为核心议题而非附属内容。

History

• Journal of Intensive Medicine was created in 2021 by the Chinese Medical Association, which owns the title.本刊由（Chinese Medical Association）于 2021 年创办，刊名归该学会所有。
• Elsevier took on publication, and the first volume appeared in July 2021.（Elsevier）承接出版事务，第 1 卷于 2021 年 7 月面世。
• It was launched as a fully open access journal from the first issue rather than converting later.刊物自创刊号起即以完全开放获取方式发行，而非日后转换。
• The journal was built around a Chinese and European editorial partnership, pairing a Shanghai intensive care department with a Paris intensive care group.其编辑架构建立在中欧合作之上，将上海的重症医学科与巴黎的重症医学团队对接。
• It publishes four issues a year and relies on review articles for a large share of its content.刊物每年出版 4 期，综述占其内容的较大比重。
• It entered the Emerging Sources Citation Index, and the impact factor rose from 3.3 in 2024 to 5.6 in 2025.刊物被（Emerging Sources Citation Index）收录，影响因子由 2024 年的 3.3 升至 2025 年的 5.6。

Editors

• Dechang Chen of the intensive care department at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, is co-editor-in-chief.（Shanghai Jiao Tong University School of Medicine）附属瑞金医院重症医学科的（Dechang Chen）任共同主编。
• Jean-Louis Teboul of the Paris-Saclay University medical school is the second co-editor-in-chief, working on haemodynamics and cardiopulmonary interaction.（Paris-Saclay University）医学院的（Jean-Louis Teboul）为另一位共同主编，研究方向为血流动力学与心肺交互。
• Associate editors include Djillali Annane and Arnaud W. Thille of France, Giuseppe Citerio of Milan-Bicocca and Daniel De Backer of Belgium.副编辑包括法国的（Djillali Annane）与（Arnaud W. Thille）、米兰比可卡大学的（Giuseppe Citerio）以及比利时的（Daniel De Backer）。
• Craig M. Coopersmith of Emory University, Bin Du of Peking Union Medical College Hospital, Jiao Liu of Ruijin Hospital and Yi Yang of Southeast University complete the associate editor group.（Emory University）的（Craig M. Coopersmith）、（Peking Union Medical College Hospital）的（Bin Du）、瑞金医院的（Jiao Liu）与（Southeast University）的（Yi Yang）构成副编辑团队。
• The board spans about eighteen countries, with around twenty members from China and substantial groups from the United States and France.编委会覆盖约 18 个国家，其中中国约 20 位，美国与法国亦占相当比例。
• Review is single anonymized, submissions run through Elsevier's editorial system, and articles are released open access immediately on acceptance.评审采用单匿名制，稿件经（Elsevier）编辑系统流转，文章录用后即开放获取发布。